Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern Africa.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Breast and cervical cancer are the most common cancers among women in East and Southern Africa, where mortality remains high because of late diagnosis and limited access to treatment. We explored local approaches to breast and cervical cancer advocacy to identify the most pressing issues and opportunities for increasing the impact of civil society activities in the region. Focus group discussions were conducted with participants of the 2016 Women's Empowerment Cancer Advocacy Network (WE CAN) Summit in Nairobi, Kenya. Discussions were audio-recorded, transcribed, coded, and analyzed for emergent themes. Results were presented to participants of 2019 WE CAN summit for cross-validation. Four focus group discussions were conducted with 50 participants. Thirty-six (70%) identified as advocates, 30 (59%) as cancer survivors, 14 (27%) as nongovernmental organization representatives, 13 (25%) as researchers, 4 (8%) as clinicians, and 6 (8%) as policymakers. Although most participants focused on cancer awareness and screening/early detection, some noted that treatment was often unavailable and advocated for a broader strategy to improving access to care. Challenges to designing and implementing such a strategy included knowledge gaps in addressing late diagnosis and access to care, difficulty collaborating with like-minded organizations, approaching policymakers, and addressing treatment financing. Cancer coalitions, although rare, were crucial to building collaborations with ministries of health, policymakers, and international organizations that advanced breast and cervical cancer care. Participants indicated that they would benefit from additional training about resource-appropriate best practices for improving breast and cervical cancer care and outcomes. Coalition-building and collaborations, including with oncologists and other medical professionals involved in cancer care, were crucial to leveraging limited resources, sharing lessons learned, and developing local solutions to common challenges.

Identifiants

pubmed: 32031438
doi: 10.1200/JGO.19.00219
pmc: PMC6998024
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-55

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Références

Ann Surg Oncol. 2015 Mar;22(3):728-33
pubmed: 25605513
J Glob Oncol. 2018 Sep;4:1-7
pubmed: 30241140
Glob Public Health. 2015;10(3):331-44
pubmed: 25443995
J Clin Oncol. 2011 Aug 1;29(22):3097-102
pubmed: 21709190
J Glob Oncol. 2016 Jul 6;3(2):162-168
pubmed: 28717754
Oncologist. 2015 Jul;20(7):780-8
pubmed: 26032138
J Surg Oncol. 2014 Dec;110(8):903-6
pubmed: 25088235
Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):519-26
pubmed: 19640202
Int J Cancer. 2018 Apr 15;142(8):1568-1579
pubmed: 29197068
BMC Womens Health. 2015;15:15
pubmed: 25783641
PLoS One. 2017 Feb 13;12(2):e0171024
pubmed: 28192444
Cancer Epidemiol. 2018 Apr;53:81-92
pubmed: 29414636
Gynecol Oncol. 2015 Dec;139(3):573-9
pubmed: 26325529
Breast Cancer Res Treat. 2014 Apr;144(3):467-78
pubmed: 24604092
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:57-62
pubmed: 28691332
J Oncol. 2010;2010:595167
pubmed: 21253541
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
Infect Agent Cancer. 2013 Jul 15;8 Suppl 1:S8
pubmed: 23902674
Cancer Causes Control. 2018 Aug;29(8):721-730
pubmed: 29980984
PLoS One. 2014 Dec 03;9(12):e110262
pubmed: 25470732
Global Health. 2018 Jan 23;14(1):9
pubmed: 29361954
Oncologist. 2016 Jun;21(6):739-44
pubmed: 27091419
Ann Epidemiol. 2017 Oct;27(10):659-671.e7
pubmed: 29128086
Infect Agent Cancer. 2013 Jul 15;8 Suppl 1:S6
pubmed: 23902653
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:153-158
pubmed: 30306578
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Darya A Kizub (DA)

The Everett Clinic, Everett, WA.

JoAnne Zujewski (J)

Leidos Biomedical Research, Fredrick, MD.

Julie R Gralow (JR)

University of Washington, Seattle, WA.
Seattle Cancer Care Alliance, Seattle, WA.

Kingsley Ndoh (K)

University of Washington, Seattle, WA.

Udie Soko (U)

Zambia Cancer Society, Lusaka, Zambia.

Allison L Dvaladze (AL)

University of Washington, Seattle, WA.
Seattle Cancer Care Alliance, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH